| Vinblastine |
II-9569/18.08.2004 |
Vinblastine Teva, Powder and solvent for solution for injection, 10, mg, Pack: 1 |
Тева Фармасютикълс България ЕООД, България |
Pharmachemie BV, The Netherlands; |
13.81 |
2.76 |
16.57 |
6% |
0.83 |
14.64 |
2.93 |
17.57 |
18% |
2.49 |
17.13 |
3.43 |
20.56 |
|
КЦ-833/23.04.2009 |
02.06.2009 |
02.06.2009 |
Неактивен |
1702 |
| Vinorelbine |
20060823/26.02.2012 |
Vinorelbin Actavis, Concentrate for solution for infusion, 50, mg, Pack: 1 |
Актавис EАД, България |
S.C.Sindan-Pharma S.R.L., Румъния; Actavis Italy S.p.A., Италия |
49.99 |
10 |
59.99 |
4% |
2 |
51.99 |
10.4 |
62.39 |
16% |
8 |
59.99 |
12 |
71.99 |
|
HCР-468/09.07.2013 |
25.07.2013 |
25.07.2013 |
Активен |
1973 |
| Vinorelbine |
II-15561/29.12.2006 |
Vinorelbin Actavis, Concentrate for solution for infusion, 50, mg, Pack: 1 |
Актавис EАД, България |
S.C.Sindan-Pharma S.R.L., Румъния; Actavis Italy S.p.A., Италия |
110 |
22 |
132 |
4% |
4.4 |
114.4 |
22.88 |
137.28 |
16% |
17.6 |
132 |
26.4 |
158.4 |
промяна на обстоятелства решение КЦРР-2853/20.03.2013 |
КЦ-507/06.02.2009 |
19.02.2009 |
19.02.2009 |
Неактивен |
1973 |
| Vinorelbine |
20060702 |
VINORELBIN "EBEWE", Concentrate for solution for infusion, 10 mg/ml - 5 ml, mg, Pack: 1 |
Ebewe Pharma GmbH. N.fg. KG,, Австрия |
Ebewe Pharma Ges.m.b.H. N.fg. KG, Austria |
54.86 |
10.97 |
65.83 |
4% |
2.19 |
57.05 |
11.41 |
68.46 |
16% |
8.78 |
65.83 |
13.17 |
79 |
промяна в обстоятелства НСР-10530/06.10.2016 |
HCР-5552/29.01.2015 |
12.02.2015 |
02.11.2016 |
Активен |
3561 |
| Vinorelbine |
ІІ-15151/07.12.2006 г. |
VINORELBIN "EBEWE", Concentrate for solution for infusion, 10 mg/ml - 5 ml, mg, Pack: 1 |
Ebewe Pharma GmbH. N.fg. KG,, Австрия |
Ebewe Pharma Ges.m.b.H. N.fg. KG, Austria |
54.86 |
10.97 |
65.83 |
4% |
2.19 |
57.05 |
11.41 |
68.46 |
16% |
8.78 |
65.83 |
13.17 |
79 |
|
HCР-5552/29.01.2015 |
12.02.2015 |
12.02.2015 |
Неактивен |
3561 |
| Vinorelbine |
ІІ-15151/07.12.2006 г. |
VINORELBIN "EBEWE", Concentrate for solution for infusion, 10 mg/ml - 1ml, mg, Pack: 1 |
Ebewe Pharma GmbH. N.fg. KG,, Австрия |
Ebewe Pharma Ges.m.b.H. N.fg. KG, Austria |
12.32 |
2.46 |
14.78 |
6% |
0.74 |
13.06 |
2.61 |
15.67 |
18% |
2.22 |
15.28 |
3.06 |
18.34 |
Цената е вписана в регистъра на пределните цени с решение НСР-2578/24.01.2014 |
HCР-2130/14.12.2013 |
30.12.2013 |
30.12.2013 |
Заличен |
2359 |
| Vinorelbine |
ІІ-15151/07.12.2006 г. |
VINORELBIN "EBEWE", Concentrate for solution for infusion, 10 mg/ml - 5 ml, mg, Pack: 1 |
Ebewe Pharma GmbH. N.fg. KG,, Австрия |
Ebewe Pharma Ges.m.b.H. N.fg. KG, Austria |
61.61 |
12.32 |
73.93 |
4% |
2.46 |
64.07 |
12.81 |
76.88 |
16% |
9.86 |
73.93 |
14.79 |
88.72 |
|
HCР-2130/14.12.2013 |
30.12.2013 |
30.12.2013 |
Неактивен |
3561 |
| Vinorelbine |
ІІ-15151/07.12.2006 г. |
VINORELBIN "EBEWE", Concentrate for solution for infusion, 10 mg/ml - 1ml, mg, Pack: 1 |
Ebewe Pharma GmbH. N.fg. KG,, Австрия |
Ebewe Pharma Ges.m.b.H. N.fg. KG, Austria |
17.88 |
3.58 |
21.46 |
6% |
1.07 |
18.95 |
3.79 |
22.74 |
18% |
3.22 |
22.17 |
4.43 |
26.6 |
|
КЦРР-2510/06.03.2013 |
20.03.2013 |
20.03.2013 |
Неактивен |
2359 |
| Vinorelbine |
ІІ-15151/07.12.2006 г. |
VINORELBIN "EBEWE", Concentrate for solution for infusion, 10 mg/ml - 5 ml, mg, Pack: 1 |
Ebewe Pharma GmbH. N.fg. KG,, Австрия |
Ebewe Pharma Ges.m.b.H. N.fg. KG, Austria |
88.5 |
17.7 |
106.2 |
4% |
3.54 |
92.04 |
18.41 |
110.45 |
16% |
14.16 |
106.2 |
21.24 |
127.44 |
|
КЦРР-2509/06.03.2013 |
20.03.2013 |
20.03.2013 |
Неактивен |
3561 |
| Vinorelbine |
ІІ-15151/ 07.12.2006 г. |
VINORELBIN "EBEWE", Concentrate for solution for infusion, 10 mg/ml - 1ml, mg, Pack: 1 |
Ebewe Pharma GmbH. N.fg. KG,, Австрия |
Ebewe Pharma Ges.m.b.H. N.fg. KG, Austria |
27.71 |
5.54 |
33.25 |
6% |
1.66 |
29.37 |
5.87 |
35.24 |
18% |
4.99 |
34.36 |
6.87 |
41.23 |
|
КЦРР-669/30.05.2012 |
14.06.2012 |
14.06.2012 |
Неактивен |
2359 |
| Vinorelbine |
ІІ-15151/ 07.12.2006 г. |
VINORELBIN "EBEWE", Concentrate for solution for infusion, 10 mg/ml - 5 ml, mg, Pack: 1 |
Ebewe Pharma GmbH. N.fg. KG,, Австрия |
Ebewe Pharma Ges.m.b.H. N.fg. KG, Austria |
97.2 |
19.44 |
116.64 |
4% |
3.89 |
101.09 |
20.22 |
121.31 |
16% |
15.55 |
116.64 |
23.33 |
139.97 |
|
КЦРР-669/30.05.2012 |
14.06.2012 |
14.06.2012 |
Неактивен |
3561 |
| Vinorelbine |
ІІ-15151/07.12.2006 г. |
VINORELBIN "EBEWE", Concentrate for solution for infusion, 10 mg/ml - 1ml, mg, Pack: 1 |
Ebewe Pharma GmbH. N.fg. KG,, Австрия |
Ebewe Pharma Ges.m.b.H. N.fg. KG, Austria |
29.14 |
5.83 |
34.97 |
8% |
2.33 |
31.47 |
6.29 |
37.76 |
20% |
5.83 |
37.3 |
7.46 |
44.76 |
|
КЦ-1346/01.02.2010 |
22.02.2010 |
22.02.2010 |
Неактивен |
2359 |
| Vinorelbine |
ІІ-15151/07.12.2006 г. |
VINORELBIN "EBEWE", Concentrate for solution for infusion, 10 mg/ml - 5 ml, mg, Pack: 1 |
Ebewe Pharma GmbH. N.fg. KG,, Австрия |
Ebewe Pharma Ges.m.b.H. N.fg. KG, Austria |
140.72 |
28.14 |
168.86 |
6% |
8.44 |
149.16 |
29.83 |
178.99 |
18% |
25.33 |
174.49 |
34.9 |
209.39 |
|
КЦ-1346/01.02.2010 |
22.02.2010 |
22.02.2010 |
Неактивен |
3561 |
| Vinpocetine |
ІІ-12901/28.04.2006 г. |
Vinpocetine Covex, Tablet, 5, mg, Pack: 50 |
Covex S.A., Испания |
Kern Pharma S.L. Spain |
3.85 |
0.77 |
4.62 |
7% |
0.27 |
4.12 |
0.82 |
4.94 |
20% |
0.77 |
4.89 |
0.98 |
5.87 |
КЦPP-516/19.04.2012 промяна на обстоятелства |
КЦ-341/17.12.2008 |
12.01.2009 |
12.01.2009 |
Активен |
321 |
| Vinpocetine |
ІІ-12901/28.04.2006 г. |
Vinpocetine Covex, Tablet, 5, mg, Pack: 25 |
Covex S.A., Испания |
Kern Pharma S.L. Spain |
2.03 |
0.41 |
2.44 |
7% |
0.14 |
2.17 |
0.43 |
2.6 |
20% |
0.41 |
2.58 |
0.52 |
3.1 |
КЦPP-515/19.04.2012 промяна на обстоятелства |
КЦ-341/17.12.2008 |
12.01.2009 |
12.01.2009 |
Активен |
320 |
| Nevirapine |
EU/1/97/055/003 |
VIRAMUNE, Tablet, 200, mg, Pack: 60 |
Boehringer Ingelheim International GmbH, Германия |
Boehringer Ingelheim Pharma GmbH & Co.KG, Germany; Boehringer Ingelheim Ellas A.E., Greece |
271.7 |
54.34 |
326.04 |
4% |
10 |
281.7 |
56.34 |
338.04 |
16% |
25 |
306.7 |
61.34 |
368.04 |
цената се заличава HCР-500/11.07.2013 |
НСР-23/03.06.2013 |
26.06.2013 |
26.06.2013 |
Заличен |
1864 |
| Nevirapine |
EU/1/97/055/003 |
VIRAMUNE, Tablet, 200, mg, Pack: 60 |
Boehringer Ingelheim International GmbH, Германия |
Boehringer Ingelheim Pharma GmbH & Co.KG, Germany; Boehringer Ingelheim Ellas A.E., Greece |
273.23 |
54.65 |
327.88 |
4% |
10 |
283.23 |
56.65 |
339.88 |
16% |
25 |
308.23 |
61.65 |
369.88 |
|
КЦРР-1122/02.08.2012 |
17.08.2012 |
17.08.2012 |
Неактивен |
1864 |
| Nevirapine |
EU/1/97/055/003 |
VIRAMUNE, Tablet, 200, mg, Pack: 60 |
Boehringer Ingelheim International GmbH, Германия |
Boehringer Ingelheim Pharma GmbH & Co.KG, Germany; Boehringer Ingelheim Ellas A.E., Greece |
281.46 |
56.29 |
337.75 |
6% |
15 |
296.46 |
59.29 |
355.75 |
18% |
30 |
326.46 |
65.29 |
391.75 |
|
КЦ-585/23.02.2009 |
18.03.2009 |
18.03.2009 |
Неактивен |
1864 |
| Tenofovir disoproxil |
EU/1/01/200/001 |
Viread, Film coated tablet, 245, mg, Pack: 30 |
Gilead Sciences International Ltd., Обединено Кралство |
Gilead Sciences Limited Ltd, Ireland; Altana Pharma Oranienburger GmbH , Germany |
472.14 |
94.43 |
566.57 |
4% |
10 |
482.14 |
96.43 |
578.57 |
16% |
25 |
507.14 |
101.43 |
608.57 |
|
НСР-7692/10.12.2015. |
26.12.2015 |
26.12.2015 |
Активен |
3712 |
| Tenofovir disoproxil |
EU/1/01/200/001 |
Viread, Film coated tablet, 245, mg, Pack: 30 |
Gilead Sciences International Ltd., Обединено Кралство |
Gilead Sciences Limited Ltd, Ireland; Altana Pharma Oranienburger GmbH , Germany |
477.12 |
95.42 |
572.54 |
4% |
10 |
487.12 |
97.42 |
584.54 |
16% |
25 |
512.12 |
102.42 |
614.54 |
|
НСР-5914/27.03.2015 |
10.04.2015 |
10.04.2015 |
Неактивен |
3712 |
| Tenofovir disoproxil |
EU/1/01/200/001 |
Viread, Film coated tablet, 245, mg, Pack: 30 |
Gilead Sciences International Ltd., Обединено Кралство |
Gilead Sciences Limited Ltd, Ireland; Altana Pharma Oranienburger GmbH , Germany |
479.8 |
95.96 |
575.76 |
4% |
10 |
489.8 |
97.96 |
587.76 |
16% |
25 |
514.8 |
102.96 |
617.76 |
|
НСР-2191/20.12.2013 |
23.01.2014 |
23.01.2014 |
Неактивен |
3712 |
| Tenofovir disoproxil |
EU/1/01/200/001 |
Viread, Film coated tablet, 245, mg, Pack: 30 |
Gilead Sciences International Ltd., Обединено Кралство |
Gilead Sciences Limited Ltd, Ireland; Altana Pharma Oranienburger GmbH , Germany |
489.88 |
97.98 |
587.86 |
4% |
10 |
499.88 |
99.98 |
599.86 |
16% |
25 |
524.88 |
104.98 |
629.86 |
|
КЦРР-568/04.05.2012 ; КЦРР-936/16.07.2012 |
06.03.2013 |
06.03.2013 |
Неактивен |
3712 |
| Tenofovir disoproxil |
EU/1/01/200/001 |
Viread, Film coated tablet, 245, mg, Pack: 30 |
Gilead Sciences International Ltd., Обединено Кралство |
Gilead Sciences Limited Ltd, Ireland; Altana Pharma Oranienburger GmbH , Germany |
560.81 |
112.16 |
672.97 |
4% |
10 |
570.81 |
114.16 |
684.97 |
16% |
25 |
595.81 |
119.16 |
714.97 |
|
КЦ-387/07.01.2009 |
27.01.2009 |
27.01.2009 |
Неактивен |
3712 |
| Dienogest |
20100101 |
Visanne, Tablet, 2 mg, -, Pack: 28 |
Bayer Pharma AG, Германия |
Bayer Weimar GmbH und Co.KG |
58.13 |
11.63 |
69.76 |
4% |
2.33 |
60.46 |
12.09 |
72.55 |
16% |
9.3 |
69.76 |
13.95 |
83.71 |
Цената e вписана в регистъра на пределните цени с решение НСР-5199/04.12.2014 |
НСР-4608/15.09.2014 |
30.09.2014 |
30.09.2014 |
Заличен |
3192 |
| Dienogest |
20100101 |
Visanne, Tablet, 2 mg, -, Pack: 28 |
Bayer Pharma AG, Германия |
Bayer Weimar GmbH und Co.KG |
65.36 |
13.07 |
78.43 |
4% |
2.61 |
67.97 |
13.59 |
81.56 |
16% |
10.46 |
78.43 |
15.69 |
94.12 |
промяна на обстоятелства НСР-2660/03.02.2014 |
НСР-2300/13.01.2014 |
28.01.2014 |
28.01.2014 |
Неактивен |
3192 |